Copyright
©The Author(s) 2015.
World J Gastrointest Oncol. Dec 15, 2015; 7(12): 445-454
Published online Dec 15, 2015. doi: 10.4251/wjgo.v7.i12.445
Published online Dec 15, 2015. doi: 10.4251/wjgo.v7.i12.445
Ref. | Year | Study size,n | CC-0,n | Median survival(mo) | CC-1,n | Median survival,(mo) | CC-0/1,n | Median survival(mo) | CC-2/3,n | Median survival(mo) |
Pestieau et al[26] | 2000 | 104 | - | - | - | - | 44 | 24 | 55 | 12 |
Verwaal et al[16] | 2003 | 49 | 18 | - | 21 | 20 | - | - | 10 | 5 |
Glehen et al[6] | 2004 | 506 | 271 | 32.4 | 106 | 24 | - | - | 129 | 8.4 |
Carmignani et al[27] | 2004 | 27 | - | - | - | - | 15 | 20.6 | 12 | 9 |
Mahteme et al[40] | 2004 | 18 | - | - | - | - | 11 | 32 | 7 | 10 |
Füzün et al[28] | 2006 | 29 | 8 | 62 | 18 | 21 | 26 | 37 | 3 | 7 |
Shen et al[29] | 2008 | 77 | 13 | NR | 35 | 15.2 | - | - | 29 | 4.5 |
Varban et al[37] | 2009 | 14 | - | - | - | - | 9 | 23 | 5 | 15.4 |
Chua et al[34] | 2010 | 58 | - | - | - | - | 3 | 19 | ||
Elias et al[17] | 2010 | 523 | 439 | 33 | 53 | 20 | - | - | 22 | 7 |
Cavaliere et al[25] | 2011 | 146 | 124 | 25 | 11 | 11 | - | - | 11 | 8 |
Mulsow et al[30] | 2011 | 125 | - | - | - | - | 31 | 25 | 94 | 8 |
Chua et al[39] | 2011 | 110 | 72 | 46 | 27 | 35 | - | - | 11 | 32 |
Matsuda et al[35] | 2012 | 153 | - | - | - | - | 31 | 42 | 122 | 10 |
Park et al[31] | 2013 | 29 | 24 | - | 0 | - | - | - | 5 | 12 |
Winer et al[32] | 2013 | 30 | 14 | - | 9 | - | 23 | 15.8 | 4 | 2.4 |
Huang et al[38] with HIPEC | 2013 | 33 | - | - | - | - | 14 | 21.7 | 19 | 11 |
Huang et al[38] without HIPEC | 2013 | 29 | - | - | - | - | 9 | 18.3 | 20 | 5 |
Kobayashi et al[36] | 2014 | 564 | - | - | - | - | 160 | 30.5 | 404 | 12 |
Ceelen et al[33] | 2014 | 166 | 79 | 49 | 66 | 22 | - | - | 21 | 12 |
Ref. | Year | Study size,n | Control1median survival(mo) | CC-2/3,n | Median survival (mo) | 1 yr | 2 yr | 3 yr | 4 yr | 5 yr |
Pestieau et al[26] | 2000 | 104 | - | 55 | 12 | - | - | - | - | 0.0% |
Verwaal et al[16] | 2003 | 49 | 12.6 | 10 | 5 | - | - | - | - | - |
Glehen et al[6] | 2004 | 506 | - | 129 | 8.4 | 38.0% | - | 6.0% | - | 0.0% |
Carmignani et al[27] | 2004 | 27 | - | 12 | 9 | - | - | - | - | - |
Mahteme et al[40] | 2004 | 18 | 14 | 7 | 10 | - | - | - | - | - |
Füzün et al[28] | 2006 | 29 | - | 3 | 7 | - | - | - | - | - |
Shen et al[29] | 2008 | 77 | - | 29 | 4.5 | - | - | 6.0% | - | 0.0% |
Varban et al[37] | 2009 | 14 | - | 5 | 15.4 | - | 40.0% | - | 20.8% | - |
Chua et al[34] | 2010 | 58 | - | 3 | 19 | - | - | - | - | 0.0% |
Elias et al[17] | 2010 | 523 | - | 22 | 7 | - | - | 8.5% | - | 0.0% |
Cavaliere et al[25] | 2011 | 146 | - | 11 | 8 | - | 0.0% | - | - | 0.0% |
Mulsow et al[30] | 2011 | 125 | - | 94 | 8 | 39.0% | 17.0% | - | - | 3.0% |
Chua et al[39] | 2011 | 110 | - | 11 | 32 | - | - | - | - | - |
Matsuda et al[35] | 2012 | 153 | - | 122 | 10 | - | - | - | - | 0.0% |
Park et al[31] | 2013 | 29 | - | 5 | 12 | - | - | 0.0% | - | 0.0% |
Winer et al[32] | 2013 | 30 | - | 4 | 2.4 | - | - | - | - | - |
Huang et al[38] with HIPEC | 2013 | 33 | - | 19 | 11 | - | - | - | - | - |
Huang et al[38] without HIPEC | 2013 | 29 | - | 20 | 5 | - | - | - | - | - |
Kobayashi et al[36] | 2014 | 564 | - | 404 | 12 | - | - | - | - | 4.7% |
Ceelen et al[33] | 2014 | 166 | - | 21 | 12 | - | - | - | - | - |
Ref. | CC-2/3, n | Median survival (mo) |
With intraperitoneal chemotherapy | ||
Shen et al[29] | 29 | 4.5 |
Verwaal et al[16] | 10 | 5 |
Elias et al[17] | 22 | 7 |
Füzün et al[28] | 3 | 7 |
Glehen et al[6] | 129 | 8.4 |
Carmignani et al[27] | 12 | 9 |
Mahteme et al[40] | 7 | 10 |
Huang et al[38] with HIPEC | 19 | 11 |
Park et al[31] | 5 | 12 |
Ceelen et al[33] | 21 | 12 |
Pestieau et al[26] | 55 | 12 |
Varban et al[37] | 5 | 15.4 |
Chua et al[34] | 3 | 19 |
Chua et al[39] | 11 | 32 |
Without intraperitoneal chemotherapy | ||
Winer et al[32] | 4 | 2.4 |
Huang et al[38] without HIPEC | 20 | 5 |
Cavaliere et al[25] | 11 | 8 |
Mulsow et al[30] | 94 | 8 |
Matsuda et al[35] | 122 | 10 |
Kobayashi et al[36] | 404 | 12 |
- Citation: Heaney RM, Shields C, Mulsow J. Outcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastases. World J Gastrointest Oncol 2015; 7(12): 445-454
- URL: https://www.wjgnet.com/1948-5204/full/v7/i12/445.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v7.i12.445